TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
Loading market information…
TSX · AIDX.TO · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Healwell AI Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.64% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Healwell AI Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of -CA$0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Healwell AI Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:14 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 13, 2025 | -CA$0.08-88.24% vs estimate | CA$14.09M+8.42% vs estimate |
|---|
| Q4 2024 | Mar 26, 2025 | -CA$0.10-169.95% vs estimate | CA$15.21M+5.78% vs estimate |
|---|
| Q3 2024 | Nov 12, 2024 | -CA$0.06-33.33% vs estimate | CA$13.74M-4.43% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
CA$33.67+CA$0.85 (+2.59%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.2% below the high.
$13.08-$0.56 (-4.11%)
AbCellera Biologics Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.92% below the high.
CA$11.13+CA$0.11 (+1.0%)
Financial 15 Split Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.55% below the high.
CA$15.17+CA$0.11 (+0.73%)
Canadian Banc Corp.’s quoted price sits in the upper half of its reported 52-week range, 14.39% below the high.
CA$24.35+CA$0.05 (+0.21%)
Brookfield Office Properties Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.29% below the high.
CA$19.19+CA$0.09 (+0.47%)
Infrastructure Dividend Split Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.72% below the high.
CA$8.95+CA$0.65 (+7.83%)
US Financial 15 Split Corp’s quoted price sits in the upper half of its reported 52-week range, 10.05% below the high.
